443 related items for PubMed ID: 15042114
1. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA, Punzi CF.
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[Abstract] [Full Text] [Related]
2.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
3. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
Conter HS, McKay DW, Reiz RJ.
Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
[Abstract] [Full Text] [Related]
4. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B.
Curr Med Res Opin; 2001 Oct; 17(1):8-17. PubMed ID: 11464450
[Abstract] [Full Text] [Related]
5. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
Teitelbaum I, Chilvers M, Reiz RJ.
Can J Cardiol; 2004 Oct; 20 Suppl C():11C-16C. PubMed ID: 16807618
[Abstract] [Full Text] [Related]
6. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
Sachse A, Verboom CN, Jäger B.
J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
[Abstract] [Full Text] [Related]
7. The effect of treatment with eprosartan on pulse pressure: factors predicting response.
de la Sierra A, Muñoz A, Arcos E, López JS, Relats J, ETAPA-2 study investigators.
Can J Cardiol; 2004 Oct; 20 Suppl C():17C-22C. PubMed ID: 16807619
[Abstract] [Full Text] [Related]
8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[Abstract] [Full Text] [Related]
9. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[Abstract] [Full Text] [Related]
10. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[Abstract] [Full Text] [Related]
11. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
Hanon O, Berrou JP, Negre-Pages L, Goch JH, Nádházi Z, Petrella R, Sedefdjian A, Sévenier F, Shlyakhto EV, Pathak A.
J Hypertens; 2008 Aug; 26(8):1642-50. PubMed ID: 18622244
[Abstract] [Full Text] [Related]
12. Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
Sega R.
Blood Press; 1999 Aug; 8(2):114-21. PubMed ID: 10451039
[Abstract] [Full Text] [Related]
13. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW.
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[Abstract] [Full Text] [Related]
14. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[Abstract] [Full Text] [Related]
15. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[Abstract] [Full Text] [Related]
16. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[Abstract] [Full Text] [Related]
17. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[Abstract] [Full Text] [Related]
18. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Villamil A, Chrysant SG, Calhoun D, Schober B, Hsu H, Matrisciano-Dimichino L, Zhang J.
J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
[Abstract] [Full Text] [Related]
19. Treatment of hypertension in the very old.
Otterstad JE, Ruilope LM.
Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
[Abstract] [Full Text] [Related]
20. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension.
Labiós M, Martínez M, Gabriel F, Guiral V, Munoz A, Aznar J.
Am J Hypertens; 2004 Sep; 17(9):757-63. PubMed ID: 15363816
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
